Dale Patterson, Ph.D. is Vice President and General Manager of Molecular Biology and Nucleic Acid Therapeutics at Thermo Fisher Scientific. When Covid-19 emerged, the Nucleic Acid Therapeutics team partnered with the leading players developing mRNA vaccines, innovated to meet the challenge and scaled its GMP manufacturing of enzymes and nucleotides – delivering more than 9 billion doses of raw materials in support of the companies who helped bring an end to the pandemic.
Dale started his career at Thermo Fisher in research and development and over the last 29 years, has held various leadership positions across product management, service and support and commercial. He spent 6 years living in the Asia Pacific region serving the needs of customers in developed and emerging markets.
The next era for mRNA-based therapeutics and vaccines is here, and it’s time to move from an R&D mindset to a focus on long-term success with mRNA and bringing these innovative therapeutics to patients at scale.